CanSino to conduct Phase III Covid-19 vaccine trial in Saudi Arabia
China-based CanSino Biologics is set to launch a Phase III clinical trial of its Covid-19 vaccine candidate, Ad5-nCOV, in Saudi…

China-based CanSino Biologics is set to launch a Phase III clinical trial of its Covid-19 vaccine candidate, Ad5-nCOV, in Saudi…